Bristol-Myers Squibb To Acquire 2seventy bio - A Sad But Inevitable End To A Cell Therapy Pioneer
Bristol-Myers Squibb acquires 2seventy bio for $286M, marking the end of a once-promising biotech. Check out if this is a ...
Nature15y
Bristol-Myers Squibb swallows last of antibody pioneers
The impending merger between Bristol-Myers Squibb (BMS) and Medarex marks the ... One by one, its generation of biotech firms, like Abgenix, Cambridge Antibody Technology and Celltech, has been ...
2seventy Bio Shares Soar Premarket on Deal to be Acquired by Bristol Myers
Shares of 2seventy bio took flight Tuesday after the biotechnology company agreed to be acquired by partner Bristol Myers Squibb. Bristol Myers is paying $5 a share in cash for 2seventy, a 79% premium ...
Nasdaq1mon
Bristol Myers Squibb Reaches Analyst Target Price
In recent trading, shares of Bristol Myers Squibb Co. (Symbol ... And so with BMY crossing above that average target price of $59.62/share, investors in BMY have been given a good signal to ...
Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million
Bristol Myers Squibb will acquire 2seventy bio for about $286 million in cash, sending the cancer cell therapy maker's shares ...
Morningstar7d
2seventy Bio Shares Soar Premarket on Deal to be Acquired by Bristol Myers
Shares of 2seventy bio took flight Tuesday after the biotechnology company agreed to be acquired by partner Bristol Myers Squibb ... price of $2.80 for the Cambridge, Mass., ...